BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 17008927)

  • 41. Liver - guardian, modifier and target of sepsis.
    Strnad P; Tacke F; Koch A; Trautwein C
    Nat Rev Gastroenterol Hepatol; 2017 Jan; 14(1):55-66. PubMed ID: 27924081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sclerosing peritonitis and mortality after liver transplantation.
    Mekeel K; Moss A; Reddy KS; Douglas D; Mulligan D
    Liver Transpl; 2009 Apr; 15(4):435-9. PubMed ID: 19326414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis.
    Aigelsreiter A; Janig E; Sostaric J; Pichler M; Unterthor D; Halasz J; Lackner C; Zatloukal K; Denk H
    Histopathology; 2009 Apr; 54(5):561-70. PubMed ID: 19413638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholangitis Lenta Causing Bile Cast Nephropathy: A Unique Model of Hepatorenal Failure in Sepsis.
    Febres Aldana CAF; Poppiti RJ
    Fetal Pediatr Pathol; 2018 Dec; 37(6):424-432. PubMed ID: 30351239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects.
    Roma MG; Crocenzi FA; Sánchez Pozzi EA
    Clin Sci (Lond); 2008 May; 114(9):567-88. PubMed ID: 18377365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug- and chemical-induced cholestasis.
    Mohi-ud-din R; Lewis JH
    Clin Liver Dis; 2004 Feb; 8(1):95-132, vii. PubMed ID: 15062196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Septic candidasis with intrahepatic cholestasis and immunoglobuline deficiency after renal transplantation.
    Zazgornik J; Schmidt P; Kopsa H; Fill W; Deutsch E
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):304-9. PubMed ID: 1106101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histological assessment of cholestasis.
    Lefkowitch JH
    Clin Liver Dis; 2004 Feb; 8(1):27-40, v. PubMed ID: 15062191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
    Chatterjee S; Premachandran S; Shukla J; Poduval TB
    J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular biology of inflammation and sepsis: a primer.
    Cinel I; Opal SM
    Crit Care Med; 2009 Jan; 37(1):291-304. PubMed ID: 19050640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
    Weismüller TJ; Wedemeyer J; Kubicka S; Strassburg CP; Manns MP
    J Hepatol; 2008; 48 Suppl 1():S38-57. PubMed ID: 18304683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cholestasis associated with sepsis in newborns].
    De Ritis L; Pecorari R; Contiero MR
    Pediatr Med Chir; 1993; 15(1):53-5. PubMed ID: 8488127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver involvement in systemic infection.
    Cook GC
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1239-47. PubMed ID: 9471032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Causes and consequences of ischemic-type biliary lesions after liver transplantation.
    Buis CI; Hoekstra H; Verdonk RC; Porte RJ
    J Hepatobiliary Pancreat Surg; 2006; 13(6):517-24. PubMed ID: 17139425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and management of cholestatic liver disease.
    Heathcote EJ
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):776-82. PubMed ID: 17628332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Post-liver transplant cholestatic disorder with biliary strictures: de novo versus recurrent primary sclerosing cholangitis.
    McPartland KJ; Lewis WD; Gordon FD; Pomfret EA; Pomposelli JJ; Jenkins R; Khettry U
    Pathol Int; 2009 May; 59(5):312-6. PubMed ID: 19432673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Granulomatous liver disease and cholestasis.
    Matheus T; Muñoz S
    Clin Liver Dis; 2004 Feb; 8(1):229-46, ix. PubMed ID: 15062203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
    Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
    Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current diagnosis and management of primary sclerosing cholangitis.
    Tischendorf JJ; Geier A; Trautwein C
    Liver Transpl; 2008 Jun; 14(6):735-46. PubMed ID: 18508363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vanishing bile duct syndrome.
    Reau NS; Jensen DM
    Clin Liver Dis; 2008 Feb; 12(1):203-17, x. PubMed ID: 18242505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.